Liu et al.138 found that both genetic and pharmacological inhibition of PERK shortened Q and T waves on ECGs (thus shortening QTc intervals), decreased ventricular tachycardia episodes, and heightened survival rates after MI, suggesting that inhibiting PERK may reduce arrhythmia risk after MI. This evidence concerns the gene EIF2AK3 and Arrhythmia.